Jaeb Center for Health Research: all 129 studies

Page 1 of 2. Open to participants first (16), then studies with results posted, then the rest; newest registration first within each.

• Longitudinal Study of Retinal Function in Eyes Treated for Diabetic Macular Edema With Anti-VEGF AgentsRecruitingNCT07567833Phase 4
• A Study of Uveitis in Children <18 Years of AgeRecruitingNCT07518134
• Omega-3 Supplementation vs Demodex vs Eyelid Cleanser for Pediatric ChalaziaNot yet recruitingNCT07496515Phase 2
• A Randomized Trial of Botulinum Toxin A vs Strabismus Surgery for Esotropia >10 to ≤30PDNot yet recruitingNCT07470164Phase 3
• Longitudinal Natural History Study of Retinal Function in Eyes of Patients With DiabetesRecruitingNCT07270133
• A RCT of Spectacles With Aspherical Lenslets or 0.05% Atropine for Myopia ControlRecruitingNCT07095894Phase 3
• CGM for the Early Detection and Management of Hyperglycemia in PregnancyRecruitingNCT06957028Not applicable
• Effect of Inhaled Technosphere Insulin vs RAA Insulin on Exercise-Induced Hypoglycemia in Adults With T1D Using Automated Insulin DeliveryRecruitingNCT06880835Not applicable
• Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)RecruitingNCT06837181
• Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDRRecruitingNCT06790784Phase 3
• Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of AgeRecruitingNCT06524882Phase 3
• Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of AgeRecruitingNCT06380517Phase 3
• Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation RetinopathyRecruitingNCT05844982Phase 3
• Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated With Rare Disease-Causing Genetic VariantsRecruitingNCT05589714
• Randomized Trial Comparing Immediate vs. Deferred Surgery for Symptomatic ERMRecruitingNCT05145491Not applicable
• A Randomized Trial to Evaluate Sequential vs Simultaneous PatchingRecruitingNCT04378790Phase 3
• Full-Time Occlusion Therapy for Intermittent Exotropia in ChildrenCompletedNCT05462821Phase 3Results posted
• Time in Glucose Hospital TargetCompletedNCT05135676Not applicableResults posted
• Virtual Diabetes Specialty Clinic: A Study Evaluating Remote Initiation of Continuous Glucose MonitoringCompletedNCT04765358Not applicableResults posted
• A Randomized Trial of Low-Dose Bevacizumab vs Laser for Type 1 ROPTerminatedNCT04634604Phase 3Results posted
• Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 DiabetesCompletedNCT04233034Phase 3Results posted
• The Insulin-Only Bionic Pancreas Pivotal TrialCompletedNCT04200313Not applicableResults posted
• Automated Insulin Delivery in Elderly With Type 1 Diabetes (AIDE T1D)CompletedNCT04016662Phase 4Results posted
• Base-in Prism Spectacles for Intermittent ExotropiaCompletedNCT03998670Not applicableResults posted
• A Pilot Study Evaluating Photobiomodulation Therapy for Diabetic Macular EdemaCompletedNCT03866473Not applicableResults posted
• Effects of Pneumatic Vitreolysis on Macular HoleCompletedNCT03677869Not applicableResults posted
• Effects of Pneumatic Vitreolysis on Vitreomacular TractionCompletedNCT03647267Phase 3Results posted
• Surgical Idiopathic Intracranial Hypertension Treatment TrialTerminatedNCT03501966Phase 3Results posted
• PROMINENT-Eye Ancillary Study (Protocol AD)TerminatedNCT03345901Phase 3Results posted
• Low-Dose Atropine for Treatment of MyopiaCompletedNCT03334253Phase 3Results posted
• DRCR.Net Aflibercept vs. Bevacizumab + Deferred Aflibercept for the Treatment of CI-DMECompletedNCT03321513Phase 3Results posted
• CGM Intervention in Teens and Young Adults With Type 1 Diabetes (T1D)CompletedNCT03263494Phase 3Results posted
• Binocular Dig Rush Game Treatment for AmblyopiaCompletedNCT02983552Not applicableResults posted
• Day and Night Closed-loop in Young People With Type 1 DiabetesCompletedNCT02925299Not applicableResults posted
• Strategies to Enhance New CGM Use in Early Childhood (SENCE)CompletedNCT02912728Not applicableResults posted
• Anti-VEGF vs. Prompt Vitrectomy for VH From PDRCompletedNCT02858076Phase 2/3Results posted
• Trial of Overminus Spectacle Therapy for Intermittent ExotropiaCompletedNCT02807350Not applicableResults posted
• Reduction of Nocturnal Hypoglycemia and Hyperglycemia in the Home Using Predictive Algorithms, Pump Suspension, and Insulin Dosing in Children and Young AdolescentsCompletedNCT02714972Not applicableResults posted
• The Use of Mini-dose Glucagon to Prevent Exercise-induced Hypoglycemia in Type 1 DiabetesCompletedNCT02660242Phase 2Results posted
• Anti-VEGF Treatment for Prevention of PDR/DMECompletedNCT02634333Phase 3Results posted
• A Prospective Observational Study of Adult StrabismusCompletedNCT02510040Results posted
• Reduction of Nocturnal Hypoglycemia and Hyperglycemia in the Home Using Predictive AlgorithmsCompletedNCT02438189Not applicableResults posted
• Mini-Dose Glucagon to Treat Non-Severe HypoglycemiaCompletedNCT02411578Phase 2Results posted
• Phase 1 Trial of Bevacizumab Treatment for Severe Retinopathy of PrematurityCompletedNCT02390531Phase 1Results posted
• A Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Type 1 DiabetesCompletedNCT02258373Not applicableResults posted
• A Pilot Clinical Trial of Overminus Spectacle Therapy for Intermittent ExotropiaCompletedNCT02223650Not applicableResults posted
• Study of Binocular Computer Activities for Treatment of AmblyopiaCompletedNCT02200211Not applicableResults posted
• Pilot Study 3 of Outpatient Control-to-Range: Safety and Efficacy With Day-and-Night In-Home UseCompletedNCT02137512Not applicableResults posted
• Phase II Combination Steroid and Anti-VEGF for Persistent DMECompletedNCT01945866Phase 2Results posted
• Treatment for CI-DME in Eyes With Very Good VA StudyCompletedNCT01909791Phase 3Results posted
• Metformin Therapy for Overweight Adolescents With Type 1 DiabetesCompletedNCT01881828Phase 3Results posted
• Outpatient Reduction of Nocturnal Hypoglycemia by Using Predictive Algorithms and Pump Suspension in ChildrenCompletedNCT01823341Phase 2Results posted
• An Outpatient Pump Shutoff Pilot Feasibility and Safety StudyCompletedNCT01736930Phase 2Results posted
• Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular EdemaCompletedNCT01627249Phase 3Results posted
• Outpatient Pump Shutoff Pilot Feasibility and Efficacy StudyCompletedNCT01591681Phase 2Results posted
• Convergence Insufficiency Treatment Study (CITS)CompletedNCT01515943Not applicableResults posted
• Hyperopia Treatment Study 1 (HTS1) - Glasses vs ObservationCompletedNCT01515475Not applicableResults posted
• Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic RetinopathyCompletedNCT01489189Phase 3Results posted
• NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)CompletedNCT01331005Phase 2Results posted
• Levodopa for the Treatment of Residual AmblyopiaCompletedNCT01190813Phase 3Results posted
• Bilateral Lateral Rectus Recession Versus Unilateral Recess-Resect for Intermittent ExotropiaCompletedNCT01032603Not applicableResults posted
• Observation Versus Occlusion Therapy for Intermittent ExotropiaCompletedNCT01032330Not applicableResults posted
• Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy (N)CompletedNCT00996437Phase 2/3Results posted
• Increasing Patching for Amblyopia in Children 3 to < 8 Years OldCompletedNCT00945100Phase 3Results posted
• Augmenting Atropine Treatment for Amblyopia in Children 3 to < 8 Years OldCompletedNCT00944710Phase 3Results posted
• Effect of Metabolic Control at Onset of Diabetes on Progression of Type 1 DiabetesTerminatedNCT00891995Phase 2/3Results posted
• Pilot Study to Evaluate Levodopa as Treatment for Residual AmblyopiaCompletedNCT00789672Phase 2Results posted
• Immediate Office Probing vs Deferred Facility Probing for Nasolacrimal Duct Obstruction in Children 6 to <10 Months OldCompletedNCT00780741Phase 3Results posted
• Randomized Trial to Assess Efficacy and Safety of Continuous Glucose Monitoring in Children 4-<10 Years With T1DMCompletedNCT00760526Phase 3Results posted
• Continuous Glucose Sensor Profiles in Non-Diabetic SubjectsCompletedNCT00717977Phase 4Results posted
• Evaluation of Vitrectomy for Diabetic Macular EdemaCompletedNCT00709319Results posted
• Observational Study of Optical Correction for Strabismic Amblyopia in Children 3 to <7 Years OldCompletedNCT00669539Results posted
• Trial Comparing Patching With Active Vision Therapy to Patching With Control Vision Therapy as Treatment for AmblyopiaTerminatedNCT00587171Phase 3Results posted
• Full-time Bangerter Filters Versus Part-time Daily Patching for Moderate Amblyopia in ChildrenCompletedNCT00525174Phase 3Results posted
• Combined Patching-Atropine for Residual AmblyopiaTerminatedNCT00506675Phase 3Results posted
• Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic RetinopathyCompletedNCT00445003Phase 3Results posted
• Laser-Ranibizumab-Triamcinolone for Diabetic Macular EdemaCompletedNCT00444600Phase 3Results posted
• Randomized Study of Real-Time Continuous Glucose Monitors (RT-CGM) in the Management of Type 1 DiabetesCompletedNCT00406133Phase 3Results posted
• A Pilot Study of Peribulbar Triamcinolone Acetonide for Diabetic Macular EdemaCompletedNCT00369486Phase 2Results posted
• Intravitreal Triamcinolone Acetonide Versus Laser for Diabetic Macular EdemaCompletedNCT00367133Phase 3Results posted
• A Phase 2 Evaluation of Anti-VEGF Therapy for Diabetic Macular Edema: Bevacizumab (Avastin)CompletedNCT00336323Phase 2Results posted
• Correction of Myopia Evaluation Trial 2CompletedNCT00320593Phase 3Results posted
• Trial Comparing Patching Versus Atropine for Amblyopia in 7 to < 13 Year OldsCompletedNCT00315328Phase 3Results posted
• Trial Comparing Atropine to Atropine Plus a Plano Lens for the Sound Eye for Amblyopia in Children 3 to <7 Years OldCompletedNCT00315302Phase 3Results posted
• T1D Pregnancy & MeActive, not recruitingNCT06959316
• Inhaled Insulin vs Rapid-acting Injections for Post-meal Glucose Control in Women With Gestational DiabetesCompletedNCT06535789Phase 2/3
• Bionic Pancreas in CFRDActive, not recruitingNCT06449677Phase 3
• Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes (CLVer): Extension StudyCompletedNCT06177691
• Loop T2D Observational StudyCompletedNCT05951569
• Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMDActive, not recruitingNCT05904028Phase 3
• Evaluation of Tonabersat for DMEActive, not recruitingNCT05727891Phase 2
• Strength and Muscle Related Outcomes for Nutrition and Lung Function in CFActive, not recruitingNCT05639556
• Bifocal Spectacles vs. Single Vision Spectacles for Esotropia Greater at NearWithdrawnNCT05527015Phase 3
• Gyrate Atrophy Ocular and Systemic StudyActive, not recruitingNCT05312736
• Rate of Progression of PCDH15-Related Retinal Degeneration in Usher Syndrome 1FActive, not recruitingNCT04765345
• Fenofibrate for Prevention of DR WorseningActive, not recruitingNCT04661358Phase 3
• Bevacizumab Treatment For Type 1 ROPActive, not recruitingNCT04634578Phase 2
• Rate of Progression in EYS Related Retinal DegenerationCompletedNCT04127006
• The Loop Observational StudyCompletedNCT03838900
• Excimer Laser Surgery for Anisometropic AmblyopiaWithdrawnNCT03342235Not applicable

← Jaeb Center for Health Research overview and focus areas